FDA launches phase 2 of animal drug database

The U.S. Food and Drug Administration’s Center for Veterinary Medicine completed the second phase of their Animal Drugs @ FDA on June 8

The U.S. Food and Drug Administration’s Center for Veterinary Medicine has launched Phase 2 of its redesigned Animal Drugs @ FDA website.

The new website provides a searchable database for veterinarians, pet owners, animal producers and others to get information about approved animal drugs by application number, sponsor name, proprietary name, ingredient, application status, dosage form, route of administration, indication and species.

The completion of Phase II on June 8, 2017, provides a “one-stop shop” for additional information related to approved animal drugs, including the migration of the following documents from FDA.gov:

  • Freedom of Information Summaries
  • Environmental Assessments
  • Findings of No Significant Impact
  • Green Book reports

The existing documents will be transitioned from FDA.gov to Animal Drugs @ FDA over the next several months, with users being directed to the new location.

In addition, all Green Book reports will now be available immediately, instead of being published annually. The reports will be provided in portable document format (PDF) and Microsoft Excel formats.

For more information about the redesigned Animal Drugs @ FDA, contact CVMGreenBookandAnimalDrug@fda.hhs.gov.

Leave a Comment

Comments

Your email address will not be published. Required fields are marked *

___

Register

Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).
 

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.